Management holds a conference call to discuss the 64th ASH Annual Meeting presentation on December 12 at 8 am. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on AGIO:
- Agios Pharmaceuticals presents updated PYRUKYND long-term extension data
- Agios Presents Updated PYRUKYND® (mitapivat) Long-term Extension Data Demonstrating Sustained Clinical Benefits in Adults with Pyruvate Kinase (PK) Deficiency at 64th ASH Annual Meeting and Exposition
- Agios Pharmaceuticals presents updated PYRUKYND data
- Agios Presents Updated PYRUKYND® (mitapivat) Data Highlighting Long-term Safety Profile and Durable Improvement in Hemoglobin and Markers of Hemolysis and Ineffective Erythropoiesis in Non-transfusion-dependent α- and β-Thalassemia at 64th ASH Annual Meeting and Exposition
- Agios Appoints Tsveta Milanova as Chief Commercial Officer